We are live on ! Find out more
CLRBW

Cellectar Biosciences, Inc.
CLRBW

Delisted

CLRBW was delisted on the 20th of August, 2019.

Back to rankings

4 hedge funds and large institutions have $9K invested in Cellectar Biosciences, Inc. in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more capital invested

Capital invested by funds: $4K → $9K (+$5K)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$774

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$5K – – –
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$4K +$774 +8,810 +27%
UBS Group
3
UBS Group
Switzerland
– -$2 -20 -5%

CLRBW Hedge Fund Activity: Q1 2019 in Review

4 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q1 2019, worth a combined $9K — up 125% from $4K a quarter earlier.

Fund positioning in CLRBW was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $774. The largest seller was UBS Group, cutting an estimated $2.

  • 4 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $9K of Cellectar Biosciences, Inc. stock for Q1 2019, up 125% quarter-over-quarter.
  • 0 funds opened new Cellectar Biosciences, Inc. positions in Q1 2019 and 0 closed out.
  • The largest Cellectar Biosciences, Inc. buyer in Q1 2019 was Susquehanna International Group, an estimated $774 added.
  • The largest Cellectar Biosciences, Inc. seller in Q1 2019 was UBS Group, an estimated $2 sold.

Based on aggregated 13F filings for Q1 2019.